Liposome-encapsulated Bacterial Antigen Against Stenotrophomonas Maltophilia Infection in Channel Catfish (ictalurus Punctatus)

汪开毓,邓龙君,肖丹,耿毅,黄小丽,陈德芳
DOI: https://doi.org/10.3321/j.issn:1005-8737.2009.05.014
2009-01-01
Journal of Fishery Sciences of China
Abstract:Liposome-encapsulated Stenotrophomonas maltophilia antigen was prepared by using reverse-phase evaporation method to investigate its potential protective efficacy for S. maltophilia infection. Channel catfish( Ictalurus punctatus) were devided into five treatment groups:Ⅰ-Ⅲ group were immunized orally with liposome-encapsulated S. maltophilia antigen at the dosage of 50 μg/ind,100 μg/ind and 200 μg/ind. Ⅳ group was immunized orally with inactived S. maltophilia antigen alone. And Ⅴ group was set as control by giving equivalent water. Vaccination was carried out 3 times at 2-week intervals. On day 1,14,28 and 49,bactericidal activity of leukocytes and content of IgM in serum were detected periodically to investigate cellular and humoral immune effects. On day 63,all fish were challenged with alive S. maltophilia(1×108 CFU/mL) by injection to estimate the protective efficacy. The liposome-encapsulated S. maltophilia antigen was successfully obtained, with mean size of( 0.9±0.3)μm. After immunization,liposome-encapsulated S. maltophilia antigen trigered significantly higher bactericidal activity and serum antibody level compared with S. maltophilia alon(eP0.05). After challenge with S. maltophilia,the relative survival rates of Ⅰ,Ⅱ, Ⅲ group,which had received different dosage of liposome-encapsulated S. maltophilia antigen,were 34.8%,48.2%,55.4%,respectively. In contrast,the relative survival rate of Ⅳ group which had received antigen of inactivated S. maltophilia was merely 6.7%,and the survival rate of the control group( Ⅴ group) was even 0. These results suggest that liposome-encapsulated S. maltophilia antigen has the potential for inducing protective immune response against atypical S. maltophilia infection and also suggest the possibility of developing a vaccine that may ultimately be used for fish disease prevention.
What problem does this paper attempt to address?